ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

A Powerful Paradigm for Cardiovascular Risk Stratification Using Multiclass, Multi-Label, and Ensemble-Based Machine Learning Paradigms: A Narrative Review

Suri, Jasjit S.*; Bhagawati, Mrinalini; Paul, Sudip; Protogerou, Athanasios D.; Sfikakis, Petros P.; Kitas, George D.; Khanna, Narendra N.; Ruzsa, Zoltan; Sharma, Aditya M.; Saxena, Sanjay; Faa, Gavino; Laird, John R.; Johri, Amer M.; Kalra, Manudeep K.; Paraskevas, Kosmas, I; Saba, Luca
Diagnostics2022-3DOI: 10.3390/diagnostics12030722
29被引3阅读
引用收藏
分享

摘要

Background and Motivation: Cardiovascular disease (CVD) causes the highest mortality globally. With escalating healthcare costs, early non-invasive CVD risk assessment is vital. Conventional methods have shown poor performance compared to more recent and fast-evolving Artificial Intelligence (AI) methods. The proposed study reviews the three most recent paradigms for CVD risk assessment, namely multiclass, multi-label, and ensemble-based methods in (i) office-based and (ii) stress-test laboratories. Methods: A total of 265 CVD-based studies were selected using the preferred reporting items for systematic reviews and meta-analyses (PRISMA) model. Due to its popularity and recent development, the study analyzed the above three paradigms using machine learning (ML) frameworks. We review comprehensively these three methods using attributes, such as architecture, applications, pro-and-cons, scientific validation, clinical evaluation, and AI risk-of-bias (RoB) in the CVD framework. These ML techniques were then extended under mobile and cloud-based infrastructure. Findings: Most popular biomarkers used were office-based, laboratory-based, image-based phenotypes, and medication usage. Surrogate carotid scanning for coronary artery risk prediction had shown promising results. Ground truth (GT) selection for AI-based training along with scientific and clinical validation is very important for CVD stratification to avoid RoB. It was observed that the most popular classification paradigm is multiclass followed by the ensemble, and multi-label. The use of deep learning techniques in CVD risk stratification is in a very early stage of development. Mobile and cloud-based AI technologies are more likely to be the future. Conclusions: AI-based methods for CVD risk assessment are most promising and successful. Choice of GT is most vital in AI-based models to prevent the RoB. The amalgamation of image-based strategies with conventional risk factors provides the highest stability when using the three CVD paradigms in non-cloud and cloud-based frameworks.

学科与关键词

关键词
CVDmulticlassmulti-labelensemblecloudCOVIDbiasgold standard
相关
加载中…
  • Cardiovascular disease/stroke risk stratification in deep learning framework: a review
    Bhagawati, Mrinalini; Paul, Sudip; Agarwal, Sushant; Protogeron, Athanasios; Sfikakis, Petros P.; Kitas, George D.; Khanna, Narendra N.; Ruzsa, Zoltan; Sharma, Aditya M.; Tomazu, Omerzu; Turk, Monika; Faa, Gavino; Tsoulfas, George; Laird, John R.; Rathore, Vijay; Johri, Amer M.; Viskovic, Klaudija; Kalra, Manudeep; Balestrieri, Antonella; Nicolaides, Andrew; Singh, Inder M.; Chaturvedi, Seemant; Paraskevas, Kosmas I.; Fouda, Mostafa M.; Saba, Luca; Suri, Jasjit S.*Cardiovascular Diagnosis and Therapy, 2023, 13(3).被引 7
  • Understanding the bias in machine learning systems for cardiovascular disease risk assessment: The first of its kind review
    Suri, Jasjit S.*; Bhagawati, Mrinalini; Paul, Sudip; Protogeron, Athanasios; Sfikakis, Petros P.; Kitas, George D.; Khanna, Narendra N.; Ruzsa, Zoltan; Sharma, Aditya M.; Saxena, Sanjay; Faa, Gavino; Paraskevas, Kosmas, I; Laird, John R.; Johri, Amer M.; Saba, Luca; Kalra, ManudeepComputers in Biology and Medicine, 2022, 142: 105204.被引 43
  • Artificial intelligence framework for predictive cardiovascular and stroke risk assessment models: A narrative review of integrated approaches using carotid ultrasound
    Jamthikar, Ankush D.; Gupta, Deep; Saba, Luca; Khanna, Narendra N.; Viskovic, Klaudija; Mavrogeni, Sophie; Laird, John R.; Sattar, Naveed; Johri, Amer M.; Pareek, Gyan; Miner, Martin; Sfikakis, Petros P.; Protogerou, Athanasios; Viswanathan, Vijay; Sharma, Aditya; Kitas, George D.; Nicolaides, Andrew; Kolluri, Raghu; Suri, Jasjit S.*Computers in Biology and Medicine, 2020, 126: 104043.被引 39
查看全部 →

发表信息

论文状态
公开发表
期刊
Diagnostics
发表日期
2022-03
卷期
第 12 卷, 第 3 期
页码
722
DOI
10.3390/diagnostics12030722
期刊等级
4区
成果收录
SCIE

作者

  • S

    Suri, Jasjit S. (通讯) (第一作者)

  • B

    Bhagawati, Mrinalini

查看全部 16 位作者收起作者
  • P

    Paul, Sudip

  • P

    Protogerou, Athanasios D.

  • S

    Sfikakis, Petros P.

  • K

    Kitas, George D.

  • K

    Khanna, Narendra N.

  • R

    Ruzsa, Zoltan

  • S

    Sharma, Aditya M.

  • S

    Saxena, Sanjay

  • F

    Faa, Gavino

  • L

    Laird, John R.

  • J

    Johri, Amer M.

  • K

    Kalra, Manudeep K.

  • P

    Paraskevas, Kosmas, I

  • S

    Saba, Luca

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417